Literature DB >> 9486604

Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability.

R Hermans1, M Feron, E Bellon, P Dupont, W Van den Bogaert, A L Baert.   

Abstract

PURPOSE: To investigate the intra- and interobserver variability of computed tomography-based volume measurements of laryngeal tumors. METHODS AND MATERIALS: The volume of 13 laryngeal tumors was repeatedly measured by five independent observers in four different sessions, using the summation-of-areas technique. Mean tumor volume and its standard deviation were calculated for each tumor. Statistical analysis was done with analysis of variance, Spearman rank correlation, and linear regression.
RESULTS: Both the effect of the observers (p < 0.0001) and the effect of the session (p < 0.01) on tumor volume was statistically significant. Interobserver variability was the most important component of total variability (89.3%). A significant rank correlation was found between mean volume and standard deviation (p < 0.01); the relationship between mean tumor volume and standard deviation can be described using linear regression [standard deviation = 0.28 volume + 0.35 (R = 0.79)].
CONCLUSION: Total variability in the computed tomography-based measurement of laryngeal tumor volume can be reduced by having the measurements done by a single trained observer.

Entities:  

Mesh:

Year:  1998        PMID: 9486604     DOI: 10.1016/s0360-3016(97)00853-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  29 in total

1.  CT perfusion in solid-body tumours. Part I: Technical issues.

Authors:  G Petralia; L Preda; G D'Andrea; S Viotti; L Bonello; R De Filippi; M Bellomi
Journal:  Radiol Med       Date:  2010-02-22       Impact factor: 3.469

2.  From anatomical to biological target volumes: the role of PET in radiation treatment planning.

Authors:  D A X Schinagl; J H A M Kaanders; W J G Oyen
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

Review 3.  PET imaging biomarkers in head and neck cancer.

Authors:  Sarah Differding; François-Xavier Hanin; Vincent Grégoire
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-09       Impact factor: 9.236

4.  Interobserver and intermodality variability in GTV delineation on simulation CT, FDG-PET, and MR Images of Head and Neck Cancer.

Authors:  Carryn M Anderson; Wenqing Sun; John M Buatti; Joan E Maley; Bruno Policeni; Sarah L Mott; John E Bayouth
Journal:  Jacobs J Radiat Oncol       Date:  2014-09

5.  Interobserver variation in clinical target volume and organs at risk segmentation in post-parotidectomy radiotherapy: can segmentation protocols help?

Authors:  M Mukesh; R Benson; R Jena; A Hoole; T Roques; C Scrase; C Martin; G A Whitfield; J Gemmill; S Jefferies
Journal:  Br J Radiol       Date:  2012-08       Impact factor: 3.039

Review 6.  Interobserver variation in parotid gland delineation: a study of its impact on intensity-modulated radiotherapy solutions with a systematic review of the literature.

Authors:  S W Loo; W M C Martin; P Smith; S Cherian; T W Roques
Journal:  Br J Radiol       Date:  2012-08       Impact factor: 3.039

7.  Tumor volume as determined by computed tomography predicts local control in hypopharyngeal squamous cell carcinoma treated with primary surgery.

Authors:  Marc Keberle; Florian Hoppe; Silke Dotzel; Dietbert Hahn
Journal:  Eur Radiol       Date:  2003-07-05       Impact factor: 5.315

8.  Tumor-volume changes after radiosurgery for vestibular schwannoma: implications for follow-up MR imaging protocol.

Authors:  O W M Meijer; E J Weijmans; D L Knol; B J Slotman; F Barkhof; W P Vandertop; J A Castelijns
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-22       Impact factor: 3.825

Review 9.  Defining the target for radiotherapy of head and neck cancer.

Authors:  S Nuyts
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

Review 10.  Tumour volume measurement in head and neck cancer.

Authors:  Vincent F H Chong
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.